A common blood test can flag early Alzheimer's disease patients who are four times more likely to experience rapid brain decline, a new study says.

Free-floating DNA carrying cancerous mutations was detected in blood three years before any other signs of cancer appeared.

A new blood test uses what is known as biomarkers to identify a person’s Alzheimer’s disease status, changing how we monitor ...

A blood test could give spinal injury patients their chance of full or partial recovery. ... About 18,000 Americans experience spinal cord injuries each year, researchers said in background notes. ...

While the American Cancer Society does not recommend “routine” prostate-specific antigen screening for men, there's a lot to ...

The blood-based test had a 79.2% sensitivity for colorectal cancer, 91.5% specificity for ACN, 90.8% negative predictive value for ACN, 15.5% positive predictive value for ACN, and 12.5% ...

The FDA has approved a new blood test for colorectal cancer. Shield, made by Guardant Health, is the first approved blood test that is considered a primary screening option for the disease.

In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement ...

Guardant’s Shield blood test was approved 1 by the FDA on July 29 for use in screening for colorectal cancer (CRC) among adults 45 years and older at average risk. The approval marks the first ...

By Jacqueline Howard, CNN (CNN) — The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older. The maker of ...

However, the blood and stool test options provide important new more inexpensive, easily done options for “interval screenings” between colonoscopies, Ogino added, and may also be important to ...